Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...

Current evidence supports existing treatment guidelines advocating LABDs (LAMA, LABA) as first-line therapy for COPD, with regular ICS therapy as an adjunct in COPD patients experiencing frequent ...

COPD worsens over time and can be life threatening without treatment. More than 11.7 million ... When symptoms first occur, some people ignore them, thinking they’re related to something less ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage to the airways. It typically refers to emphysema and chronic bronchitis.

People with COPD have a higher risk of developing pneumonia due to changes in their lung microbiome. Early detection and treatment could help reduce the risk of complications. Chronic obstructive ...